Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2025-08-27

EMA Authorised: Pregabalin Accord (pregabalin) — Accord Healthcare S.L.U.

View source ↗

Summary

The EMA authorised the generic pregabalin product Pregabalin Accord for anxiety disorders and epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin Accord (pregabalin)

Snippet

Status: Authorised. Therapeutic area: Anxiety Disorders;Epilepsy. MAH: Accord Healthcare S.L.U.. Decision date: 27/01/2025